 |
PDBsum entry 1ed5
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
1ed5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.14.13.39
- nitric-oxide synthase (NADPH).
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
2 L-arginine + 3 NADPH + 4 O2 + H+ = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O
|
 |
 |
 |
 |
 |
2
×
L-arginine
|
+
|
3
×
NADPH
Bound ligand (Het Group name = )
matches with 80.00% similarity
|
+
|
4
×
O2
|
+
|
H(+)
|
=
|
2
×
L-citrulline
|
+
|
2
×
nitric oxide
|
+
|
3
×
NADP(+)
|
+
|
4
×
H2O
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
40:13448-13455
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism.
|
|
C.S.Raman,
H.Li,
P.Martásek,
G.Southan,
B.S.Masters,
T.L.Poulos.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Nitric oxide is generated under normal and pathophysiological conditions by
three distinct isoforms of nitric oxide synthase (NOS). A small-molecule
inhibitor of NOS (3-Br-7-nitroindazole, 7-NIBr) is profoundly neuroprotective in
mouse models of stroke and Parkinson's disease. We report the crystal structure
of the catalytic heme domain of endothelial NOS complexed with 7-NIBr at 1.65 A
resolution. Critical to the binding of 7-NIBr at the substrate site is the
adoption by eNOS of an altered conformation, in which a key glutamate residue
swings out toward one of the heme propionate groups. Perturbation of the heme
propionate ensues and eliminates the cofactor tetrahydrobiopterin-heme
interaction. We also present three crystal structures that reveal how
alterations at the substrate site facilitate 7-NIBr and structurally dissimilar
ligands to occupy the cofactor site.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
R.J.Young,
W.Alderton,
A.D.Angell,
P.J.Beswick,
D.Brown,
C.L.Chambers,
M.C.Crowe,
J.Dawson,
C.C.Hamlett,
S.T.Hodgson,
S.Kleanthous,
R.G.Knowles,
L.J.Russell,
R.Stocker,
and
J.M.Woolven
(2011).
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor.
|
| |
Bioorg Med Chem Lett,
21,
3037-3040.
|
 |
|
|
|
|
 |
C.Giroud,
M.Moreau,
T.A.Mattioli,
V.Balland,
J.L.Boucher,
Y.Xu-Li,
D.J.Stuehr,
and
J.Santolini
(2010).
Role of arginine guanidinium moiety in nitric-oxide synthase mechanism of oxygen activation.
|
| |
J Biol Chem,
285,
7233-7245.
|
 |
|
|
|
|
 |
D.Lefèvre-Groboillot,
J.L.Boucher,
D.Mansuy,
and
D.J.Stuehr
(2006).
Reactivity of the heme-dioxygen complex of the inducible nitric oxide synthase in the presence of alternative substrates.
|
| |
FEBS J,
273,
180-191.
|
 |
|
|
|
|
 |
A.J.Cardounel,
Y.Xia,
and
J.L.Zweier
(2005).
Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin.
|
| |
J Biol Chem,
280,
7540-7549.
|
 |
|
|
|
|
 |
D.Lefèvre-Groboillot,
J.L.Boucher,
D.J.Stuehr,
and
D.Mansuy
(2005).
Relationship between the structure of guanidines and N-hydroxyguanidines, their binding to inducible nitric oxide synthase (iNOS) and their iNOS-catalysed oxidation to NO.
|
| |
FEBS J,
272,
3172-3183.
|
 |
|
|
|
|
 |
S.B.Kirton,
C.W.Murray,
M.L.Verdonk,
and
R.D.Taylor
(2005).
Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins.
|
| |
Proteins,
58,
836-844.
|
 |
|
|
|
|
 |
S.Y.Proskuryakov,
A.G.Konoplyannikov,
V.G.Skvortsov,
A.A.Mandrugin,
and
V.M.Fedoseev
(2005).
Structure and activity of NO synthase inhibitors specific to the L-arginine binding site.
|
| |
Biochemistry (Mosc),
70,
8.
|
 |
|
|
|
|
 |
D.Mansuy,
and
J.L.Boucher
(2004).
Alternative nitric oxide-producing substrates for NO synthases.
|
| |
Free Radic Biol Med,
37,
1105-1121.
|
 |
|
|
|
|
 |
M.L.Flinspach,
H.Li,
J.Jamal,
W.Yang,
H.Huang,
J.M.Hah,
J.A.Gómez-Vidal,
E.A.Litzinger,
R.B.Silverman,
and
T.L.Poulos
(2004).
Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.
|
| |
Nat Struct Mol Biol,
11,
54-59.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Marchal,
A.C.Gorren,
M.Sørlie,
K.K.Andersson,
B.Mayer,
and
R.Lange
(2004).
Evidence of two distinct oxygen complexes of reduced endothelial nitric oxide synthase.
|
| |
J Biol Chem,
279,
19824-19831.
|
 |
|
|
|
|
 |
J.T.Groves
(2003).
The bioinorganic chemistry of iron in oxygenases and supramolecular assemblies.
|
| |
Proc Natl Acad Sci U S A,
100,
3569-3574.
|
 |
|
|
|
|
 |
R.Fedorov,
E.Hartmann,
D.K.Ghosh,
and
I.Schlichting
(2003).
Structural basis for the specificity of the nitric-oxide synthase inhibitors W1400 and Nomega-propyl-L-Arg for the inducible and neuronal isoforms.
|
| |
J Biol Chem,
278,
45818-45825.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.J.Teague
(2003).
Implications of protein flexibility for drug discovery.
|
| |
Nat Rev Drug Discov,
2,
527-541.
|
 |
|
|
|
|
 |
A.C.Gorren,
K.Schmidt,
and
B.Mayer
(2002).
Binding of L-arginine and imidazole suggests heterogeneity of rat brain neuronal nitric oxide synthase.
|
| |
Biochemistry,
41,
7819-7829.
|
 |
|
|
|
|
 |
J.Sopková-de Oliveira Santos,
V.Collot,
and
S.Rault
(2002).
7-Methoxy-1H-indazole, a new inhibitor of neuronal nitric oxide synthase.
|
| |
Acta Crystallogr C,
58,
o688-o690.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |